Lyna Z. Schieber

1.9k total citations · 4 hit papers
19 papers, 1.3k citations indexed

About

Lyna Z. Schieber is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Lyna Z. Schieber has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Lyna Z. Schieber's work include Opioid Use Disorder Treatment (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 and Mental Health (4 papers). Lyna Z. Schieber is often cited by papers focused on Opioid Use Disorder Treatment (7 papers), COVID-19 Clinical Research Studies (4 papers) and COVID-19 and Mental Health (4 papers). Lyna Z. Schieber collaborates with scholars based in United States, Greece and Mexico. Lyna Z. Schieber's co-authors include Puja Seth, Gery P. Guy, Christine L. Mattson, Nana O. Wilson, Rose A. Rudd, Lawrence Scholl, Likang Xu, Randall Young, Adi V. Gundlapalli and William R. Mac Kenzie and has published in prestigious journals such as JAMA, JAMA Psychiatry and Drug and Alcohol Dependence.

In The Last Decade

Lyna Z. Schieber

18 papers receiving 1.2k citations

Hit Papers

Annual surveillance report of drug-related risks and outc... 2017 2026 2020 2023 2017 2021 2021 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Annual surveillance report of drug-related risks and outcomes -- United States, 2017
    2017 237 citations Christine L. Mattson, Lyna Z. Schieber et al. profile →
  2. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children
    2021 233 citations Lyudmyla Kompaniyets, Nickolas T. Agathis et al. JAMA Network Open profile →
  3. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
    2021 203 citations Lyudmyla Kompaniyets, Audrey F. Pennington et al. Preventing Chronic Disease profile →
  4. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017
    2019 183 citations Lyna Z. Schieber, Gery P. Guy et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyna Z. Schieber United States 12 572 331 271 248 186 19 1.3k
Steven Reynolds Canada 19 437 0.8× 152 0.5× 191 0.7× 363 1.5× 38 0.2× 61 1.6k
Michael S. Lyons United States 19 381 0.7× 360 1.1× 110 0.4× 629 2.5× 143 0.8× 66 1.3k
David Williamson Canada 29 173 0.3× 220 0.7× 510 1.9× 493 2.0× 119 0.6× 135 2.5k
Peter G. Brindley Canada 24 223 0.4× 195 0.6× 135 0.5× 170 0.7× 43 0.2× 103 1.7k
Régis Goulart Rosa Brazil 19 194 0.3× 122 0.4× 78 0.3× 237 1.0× 79 0.4× 97 1.4k
Julie R. Gaither United States 23 873 1.5× 236 0.7× 219 0.8× 546 2.2× 640 3.4× 58 1.8k
Darius A. Rastegar United States 18 365 0.6× 188 0.6× 69 0.3× 348 1.4× 100 0.5× 47 851
Joshua A. Barocas United States 22 868 1.5× 238 0.7× 80 0.3× 951 3.8× 294 1.6× 99 1.6k
Kirsha S. Gordon United States 24 480 0.8× 705 2.1× 135 0.5× 714 2.9× 302 1.6× 86 2.1k
Barbara Broers Switzerland 19 310 0.5× 261 0.8× 77 0.3× 655 2.6× 128 0.7× 63 1.4k

Countries citing papers authored by Lyna Z. Schieber

Since Specialization
Citations

This map shows the geographic impact of Lyna Z. Schieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyna Z. Schieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyna Z. Schieber more than expected).

Fields of papers citing papers by Lyna Z. Schieber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyna Z. Schieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyna Z. Schieber. The network helps show where Lyna Z. Schieber may publish in the future.

Co-authorship network of co-authors of Lyna Z. Schieber

This figure shows the co-authorship network connecting the top 25 collaborators of Lyna Z. Schieber. A scholar is included among the top collaborators of Lyna Z. Schieber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyna Z. Schieber. Lyna Z. Schieber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schieber, Lyna Z., et al.. (2025). Substance Use Screening, Brief Intervention, and Referral to Treatment Among Youth-Serving Clinicians. JAMA Network Open. 8(5). e2511579–e2511579. 2 indexed citations
2.
Sumner, Steven A., et al.. (2025). Large-Scale Analysis of Online Questions Related to Opioid Use Disorder on Reddit. Proceedings of the International AAAI Conference on Web and Social Media. 19. 1068–1084.
3.
Rikard, S. Michaela, Andrea E. Strahan, Lyna Z. Schieber, & Gery P. Guy. (2024). Trends in Naloxone Dispensing From Retail Pharmacies in the US. JAMA. 332(2). 165–165. 6 indexed citations
4.
Moonesinghe, Ramal, et al.. (2023). Severity Outcomes among Adult Patients with Primary Immunodeficiency and COVID-19 Seen in Emergency Departments, United States, April 2020–August 2021. Journal of Clinical Medicine. 12(10). 3516–3516. 1 indexed citations
5.
ElSherief, Mai, Steven A. Sumner, Vikram Krishnasamy, et al.. (2023). Identification of Myths and Misinformation About Treatment for Opioid Use Disorder on Social Media: Infodemiology Study. JMIR Formative Research. 8. e44726–e44726. 5 indexed citations
6.
Schieber, Lyna Z., Christopher Dunphy, Richard A. Schieber, et al.. (2023). Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021. JAMA Psychiatry. 80(4). 331–331. 9 indexed citations
7.
Montgomery, Martha P., Kristie E.N. Clarke, Samantha P. Williams, et al.. (2022). Hospitalizations for COVID-19 Among US People Experiencing Incarceration or Homelessness. JAMA Network Open. 5(1). e2143407–e2143407. 17 indexed citations
8.
Board, Amy, Sun-Kyung Kim, Joo‐Hyun Park, et al.. (2022). Risk factors for COVID-19 among persons with substance use disorder (PWSUD) with hospital visits – United States, April 2020–December 2020. Drug and Alcohol Dependence. 232. 109297–109297. 12 indexed citations
9.
10.
Kompaniyets, Lyudmyla, Nickolas T. Agathis, Jennifer Nelson, et al.. (2021). Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Network Open. 4(6). e2111182–e2111182. 233 indexed citations breakdown →
11.
Kompaniyets, Lyudmyla, Audrey F. Pennington, Alyson B. Goodman, et al.. (2021). Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021. Preventing Chronic Disease. 18. E66–E66. 203 indexed citations breakdown →
12.
Bull–Otterson, Lara, Elizabeth B. Gray, Daniel S. Budnitz, et al.. (2020). Hydroxychloroquine and Chloroquine Prescribing Patterns by Provider Specialty Following Initial Reports of Potential Benefit for COVID-19 Treatment — United States, January–June 2020. MMWR Morbidity and Mortality Weekly Report. 69(35). 1210–1215. 47 indexed citations
13.
Pennington, Audrey F., Lyudmyla Kompaniyets, April D. Summers, et al.. (2020). Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19—United States, March–September 2020. Open Forum Infectious Diseases. 8(2). ofaa638–ofaa638. 61 indexed citations
14.
Schieber, Lyna Z., Gery P. Guy, Puja Seth, & Jan L. Losby. (2020). Variation in Adult Outpatient Opioid Prescription Dispensing by Age and Sex — United States, 2008–2018. MMWR Morbidity and Mortality Weekly Report. 69(11). 298–302. 94 indexed citations
15.
Chang, Man‐Huei, Ramal Moonesinghe, Lyna Z. Schieber, & Benedict I. Truman. (2019). Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015. Journal of Clinical Medicine. 8(11). 1768–1768. 5 indexed citations
16.
Guy, Gery P., Kun Zhang, Lyna Z. Schieber, Randall Young, & Deborah Dowell. (2019). County-Level Opioid Prescribing in the United States, 2015 and 2017. JAMA Internal Medicine. 179(4). 574–574. 63 indexed citations
17.
Schieber, Lyna Z., Gery P. Guy, Puja Seth, et al.. (2019). Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017. JAMA Network Open. 2(3). e190665–e190665. 183 indexed citations breakdown →
18.
Hoots, Brooke, Likang Xu, Mbabazi Kariisa, et al.. (2018). 2018 Annual surveillance report of drug-related risks and outcomes -- United States. 85 indexed citations
19.
Mattson, Christine L., Lyna Z. Schieber, Lawrence Scholl, et al.. (2017). Annual surveillance report of drug-related risks and outcomes -- United States, 2017. 237 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Reynolds Breakdown of academic impact, for papers by Michael S. Lyons Breakdown of academic impact, for papers by David Williamson Breakdown of academic impact, for papers by Peter G. Brindley Breakdown of academic impact, for papers by Régis Goulart Rosa Breakdown of academic impact, for papers by Julie R. Gaither Breakdown of academic impact, for papers by Darius A. Rastegar Breakdown of academic impact, for papers by Joshua A. Barocas Breakdown of academic impact, for papers by Kirsha S. Gordon Breakdown of academic impact, for papers by Barbara Broers
Rankless by CCL
2026